Company news
Oxford Biodynamics Plc (LSE:OBD) news
Oxford Biodynamics Plc news releases on 6ix. Latest, Nov 6, 2018: Issue of Equity
Press releases — page 4
Issue of Equity
November 6, 2018
Consortium with OBD receives ?4m Horizon 2020 fund
September 18, 2018
Chinese Investment Group Takes Stake in OBD
August 22, 2018
Grant of Canadian patent for EpiSwitch platform
July 19, 2018
OBD presents latest EpiSwitch data at ASH Summit
July 17, 2018
ALS study published in peer reviewed journal
June 26, 2018
Interim Results for the Period Ended 31 March 2018
May 22, 2018
Publication in Journal of Translational Medicine
March 28, 2018
PDMR Dealing/Grant of Share Options
March 19, 2018
ALS biomarker data presented at World CNS Summit
March 16, 2018
Grant of Indian patent for EpiSwitch platform
February 14, 2018
Shore Capital appointed as NOMAD and Sole Broker
January 30, 2018
Collaboration in sports-related concussions
January 29, 2018
Signs 2nd agreement with US biopharma company
January 3, 2018
Exercise period extension existing Share Options
December 13, 2017
EXERCISE OF WARRANTS AND DIRECTOR DEALING
December 5, 2017
Data at FNIH Biomarker Consortium Cancer Meeting
November 15, 2017
Agreement with a major US biopharma company
November 7, 2017
Notification of major holdings
November 6, 2017
Presents at the Diabetes Asia 2017 Conference
October 13, 2017
Presents ALS signatures at NEALS
October 11, 2017
Announces grant of US patent for EpiSwitchT
October 3, 2017
Successful in diagnosing and staging breast cancer
September 28, 2017
Directorate Update
September 15, 2017
Appointment of Paul Stockdale as CFO
June 30, 2017
Targets Amyotrophic Lateral Sclerosis in Asia
June 13, 2017
Publication highlights advantages of EpiSwitchT
May 31, 2017
Development Agreements with Top Pharma Companies
May 23, 2017
Appointment of Shore Capital as Joint Broker
May 19, 2017
Subsidiary signs exclusive Asia licence
May 18, 2017
Representation on NIH steering committees
April 20, 2017
BIO-FLARE Collaboration
March 17, 2017
AGM Results and Related Party Transaction
March 15, 2017
Appointment of Martin Reeves as SVP
March 9, 2017
Appointment of Dr Claudio Carini
February 13, 2017
Pilot project with EpiFit
January 23, 2017
Admission to AIM and First Day of Dealings
December 6, 2016